Parkinson, Alzheimer, and Dementia Panel

The Parkinson, Alzheimer, and Dementia Panel analyzes genes that are associated with progressive neurodegenerative conditions affecting the nervous system, including but not limited to amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer disease, Parkinson Disease, and Parkinsonism. The genetic heterogeneity associated with these conditions can make it difficult to use phenotype as the sole criterion to select a definitive cause. These genes were curated based on the available evidence to date in order to provide analysis for hereditary dementia and ALS. Given the clinical overlap of hereditary dementia and ALS, broad panel testing allows for an efficient evaluation of several potential genes based on a single clinical indication. Some genes in this test may also be associated with additional unrelated disorders, which are not included in the list of disorders tested. Genetic testing of these genes may help confirm a clinical diagnosis, predict disease prognosis and progression, facilitate early detection of symptoms, inform family planning and genetic counseling, or promote enrollment in clinical trials.